சீனா உயர் இரத்த அழுத்தம் கணக்கெடுப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சீனா உயர் இரத்த அழுத்தம் கணக்கெடுப்பு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சீனா உயர் இரத்த அழுத்தம் கணக்கெடுப்பு Today - Breaking & Trending Today

Venus Medtech Appoints Professor Martin B. Leon as Global Principal Investigator of Its New-Generation RDN System


Share this article
Share this article
HANGZHOU, China, July 27, 2021 /PRNewswire/  On July 27, 2021, Venus Medtech (Hangzhou) Inc. ( Venus Medtech ) (stock code: 2500.HK), a leading provider of comprehensive interventional heart valve therapy solutions in China, and its controlling subsidiary Renaly Ltd., announced that Professor Martin B. Leon, MD, a pioneer in the field of interventional cardiovascular devices, has been appointed as the Global Principal Investigator (PI) for its new-generation renal artery denervation (RDN) system.
(PRNewsfoto/杭州启明医疗器械股份有限公司)
Dr. Leon is currently Professor of Medicine at Columbia University Irving Medical Center (CUIMC) in New York. He is also Director of the Center for Interventional Vascular Therapy (CIVT), Director of the Cardiac Catheterization Laboratories and the Director of the executive board of the New York-Presbyterian University Hospital of Columbia and Cornell Heart & Valve Center. In ....

Eric Zi , Medtronic Symplicity Spyral , Venus Medtech , Venus Medtech Hangzhou Inc , World Health Organization , Drug Administration , China Hypertension , Mode Ultrasound Technology , Symplicity Spyral , Renal Denervation System , Recor Medical , Ultrasonic Denervation System , Breakthrough Device Designation , Dual Mode Ultrasound Technology , China Hypertension Survey , Executive Director , Managing Director , Global Principal , Global Advisory Board , World Health Organization Report , Chinese Circulation Journal , எரிக் ஜி , வெள்ளி மெதிதேச் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , சீனா உயர் இரத்த அழுத்தம் , திருப்புமுனை சாதனம் பதவி ,

Use of Sacubitril/Valsartan Will Improve The Management of Hypertension In China


Use of Sacubitril/Valsartan Will Improve The Management of Hypertension In China
Perspectives
A
There are approximately 245 million adults with hypertension in China. According to the most recent China Hypertension Survey conducted by the National Center for Cardiovascular Disease from October 2012 to December 2015
1, hypertension awareness, treatment and control rates were 51.6%, 45.8% and 15.3%, respectively. Because of low awareness, at their initial contact with a doctor, many Chinese hypertensive patients often already show serious target organ damage or even overt cardiovascular disease, such as left ventricular hypertrophy (LVH), renal dysfunction and so on. That explains why many Chinese hypertensive patients are at high cardiovascular risk. Given the increasing longevity and prevalence of hypertension in China, there is a huge challenge in the management of hypertension in this populous country. ....

National Center , China Hypertension , China Hypertension Survey , Cardiovascular Disease , தேசிய மையம் , சீனா உயர் இரத்த அழுத்தம் , சீனா உயர் இரத்த அழுத்தம் கணக்கெடுப்பு , இருதய நோய் ,